Management of persistent anal canal carcinoma after combined-modality therapy: a clinical review
Anal canal carcinoma is a rare gastro-intestinal cancer. Radiochemotherapy is the recommended primary treatment for patients with non-metastatic carcinoma; surgery is generally reserved for persistent or recurrent disease. Follow-up and surveillance after primary treatment is paramount to classify p...
Saved in:
Published in | Radiation oncology (London, England) Vol. 9; no. 1; p. 39 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
28.01.2014
BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!